Brief: Egle Therapeutics Appoints John Celebi As Chief Executive Officer
07/01/2026 14:13
Jan 7 (Reuters) - Sensei Biotherapeutics Inc SNSE.O: EGLE THERAPEUTICS APPOINTS JOHN CELEBI AS CHIEF EXECUTIVE OFFICER Source text: ID:nGNX6zszjm Further company coverage: SNSE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments